中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

7 records (took 0.022 seconds)

    PROCESS FOR PREPARATION OF MICROCAPSULES
    1.
    发明申请
    PROCESS FOR PREPARATION OF MICROCAPSULES 有权

    公开(公告)号：US20210187466A1

    公开(公告)日：2021-06-24

    申请号：US16076123

    申请日：2017-02-02

    Applicant: BASF SE

    Inventor： Ewelina Burakowska-Meise ,  Helmut Witteler ,  Volker Bauer ,  Stefen Jemewein ,  Stephan Heuffer ,  Oliver Spangenberg ,  Stefan Fischer ,  Jesper Duus Nielsen ,  Murat Cetinkaya

    IPC: B01J13/14 ,  B01J13/22

    Abstract: A process for the preparation of microcapsules including (a) preparation of an aqueous biphasic system by mixing (i) component (a1) including a component A selected from polyethylene glycol vinyl acetate comb polymers, polycarboxylates, polyethers, polyaspartates, polyvinylpyrrolidone, polyamines, and polylysine; wherein component (a1) is a monophasic system at 23° C., and forms a monophasic system at 23° C. if mixed with water in the range of from 1:99 to 99:1 by weight, and (ii) component (a2) containing water and a water-soluble component B, wherein water-soluble component B is different from component A, and wherein (a2) is a monophasic system at 23° C., (iii) at least one monomer (a3), and (iv) optionally at least one initiator (a4), wherein (a1), (a2), (a3), and (a4) can be mixed together in any order or simultaneously, followed by (b) optionally shearing of the biphasic system to form an emulsion, and (c) polymerization of monomer (a3).

    COMPOUNDS STABILIZING AMYLASES IN LIQUIDS
    6.
    发明申请
    COMPOUNDS STABILIZING AMYLASES IN LIQUIDS 有权

    公开(公告)号：US20220112479A1

    公开(公告)日：2022-04-14

    申请号：US17281719

    申请日：2019-09-24

    Applicant: BASF SE

    Inventor： Stephan Hueffer ,  Oliver Spangenberg ,  Alejandra Garcia Marcos ,  Heike Weber ,  Katrin-Stephanie Tuecking ,  Stefan Fischer

    IPC: C12N9/96 ,  C11D3/20 ,  C11D3/386

    Abstract: Described herein is an enzyme preparation including Component (a): at least one compound according to general formula (I) wherein R1 is H; R2, R3, R4 are independently from each other selected from the group consisting of H, linear C1-C8 alkyl, and branched C3-C8 alkyl, C6-C10-aryl, non-substituted or substituted with one or more carboxylate or hydroxyl groups, and C6-C10-aryl-alkyl, wherein an alkyl of the C6-C10-aryl-alkyl is selected from the group consisting of linear C1-C8 alkyl and branched C3-C8 alkyl, wherein at least one of R2, R3, and R4 is not H, component (b): at least one enzyme selected from the group consisting of hydrolases (EC 3) and proteases component (c): at least one compound selected from the group consisting of solvents, enzyme stabilizers different from component (a), and compounds stabilizing the enzyme preparation.

    ACTIVITY BASED ENZYME INVENTORY MANAGEMENT
    7.
    发明申请
    ACTIVITY BASED ENZYME INVENTORY MANAGEMENT 有权

    公开(公告)号：US20220284391A1

    公开(公告)日：2022-09-08

    申请号：US17632609

    申请日：2020-09-10

    Applicant: BASF SE

    Inventor： Stefan Fischer ,  Jesper Nielsen ,  Simeon Sauer ,  Grit Baier

    IPC: G06Q10/08 ,  G06Q50/28 ,  G01K3/04

    Abstract: The present invention relates to a computer-implemented method for activity based enzyme formulation management of an enzyme formulation comprising (i) receiving input data, preferably via an input unit (10), of at least one storage segment data defined by at least temperature and storage duration and an initial enzyme activity value of said enzyme Predicted degradation formulation; (ii) determining, specifically calculating, a remaining activity value of the enzyme formulation based on the storage segment data and the initial enzyme activity value via a processing unit (20); (iii) providing a remaining activity value for the enzyme formulation, preferably via an output unit (30), and (iv) managing said enzyme formulation based on the remaining activity value of step (iii), said managing preferably comprising at least one of—providing a dosage recommendation based on the remaining activity value of the enzyme formulation, preferably via an output unit (30);—providing a residual shelf life indicator for said enzyme formulation based on the remaining activity value of the enzyme formulation; —automated adjustment of a dosage of the enzyme formulation by controlling of a dosing equipment; and/or—eliciting an order of a batch of enzyme formulation if the remaining activity value is indicative of the total enzyme activity in the enzyme formulation being below a pre- determined threshold value. The present invention also relates to an apparatus for activity based enzyme formulation management of an enzyme formulation, comprising: —an input unit (10) configured to receive a data input, preferably a user interface, wherein the data input comprises storage segment data defined by at least temperature and duration and an initial enzyme activity value of said enzyme formulation; —a processing unit (20), preferably a processing unit comprising at least one processor, configured, specifically by programming, to determine, specifically to calculate, a remaining activity value of the enzyme formulation based on the storage segment data and the initial enzyme activity value; and—an output unit (30) configured to output the remaining activity value for the enzyme formulation to the user and/or to a data interface.; and to a system comprising said apparatus. The present invention further relates to methods, computer programs, data carriers, and uses related to the aforesaid method, apparatus, and system.

Patent Agency Ranking